Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS • Currently up 1.07 (+2.40%) in today's trading session

1 member of Congress has disclosed 2 trades in Ionis Pharmaceuticals, Inc. (IONS) via STOCK Act filings. The most recent disclosure was a sale by Sheldon Whitehouse on 20 January 2016. Aggregate disclosed activity totals roughly $16K in sales (midpoint estimates from bracketed disclosure amounts).

Ionis Pharmaceuticals, Inc. is currently trading at $45.57, positioned at 6% of its 52-week range ($43.01 – $86.74).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$45.57
24h Change
+1.07 (+2.40%)
52 Week Range
$43.01–$86.74
View on NASDAQ

Ionis Pharmaceuticals, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for IONS

Select to highlight on chart
2 transactions
Compliance: 50%
Sheldon Whitehouse20 Jan 201623 Feb 2016SaleStock$1,001 - $15,000N/A
Sheldon Whitehouse20 Jan 201611 Aug 2017SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$7.4B

Volume

3.55M

Beta

0.42

P/E Ratio

-13.94

Fundamentals

EPS

$-3.27

Div. Yield

-

Open

$44.45

Day Range

$44.06 – $46.95

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Brett Monia
IPO Date
1991-05-17
Website
www.ionis.com

Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes...

Earnings

Next Report

Q3 2026

4 Nov

EPS Est.

$-1.21

Rev. Est.

$182.4M

Days Until

37

Recent Quarters

Q2 202629 Jul
EPS$-0.69
Beat 36.7%
Q1 202629 Apr
EPS$-0.56
Beat 34.1%
Q4 202525 Feb
EPS$-1.41
Miss 14.0%
Q3 202529 Oct
EPS$-0.61
Beat 47.0%
Q2 202530 Jul
EPS$0.86
Beat 218.5%
Q1 202530 Apr
EPS$-0.75
Beat 32.4%
Q4 202419 Feb
EPS$-0.66
Beat 39.5%
Q3 20246 Nov
EPS$-0.95
Beat 18.1%
Q2 20241 Aug
EPS$-0.45
Beat 51.1%
Q1 20247 May
EPS$-0.98
Beat 6.4%
Q4 202321 Feb
EPS$-0.06
Beat 92.8%
Q3 20232 Nov
EPS$-1.03
Beat 1.0%
Q2 20239 Aug
EPS$-0.60
Beat 33.3%
Q1 20233 May
EPS$-0.87
Beat 4.4%
Q4 202222 Feb
EPS$-0.37
Beat 65.1%
Q3 20229 Nov
EPS$-0.33
Beat 55.4%
Q2 20229 Aug
EPS$-0.74
Miss 19.4%
Q1 20224 May
EPS$-0.46
Beat 35.2%
Q4 202124 Feb
EPS$1.41
Beat 403.6%
Q3 20213 Nov
EPS$-0.58
Miss 9.4%
Q2 20214 Aug
EPS$-0.57
Beat 5.0%
Q1 20215 May
EPS$-0.64
Miss 20.8%
Q4 202024 Feb
EPS$-2.44
Miss 1116.7%
Q3 20204 Nov
EPS$-0.22
Miss 144.4%
Q2 20205 Aug
EPS$-0.23
Beat 17.9%
Q1 20206 May
EPS$-0.10
Beat 9.1%
Q4 201926 Feb
EPS$1.41
Beat 51.6%
Q3 20196 Nov
EPS$0.18
Beat 156.3%
Q2 20197 Aug
EPS$-0.01
Beat 96.3%
Q1 20199 May
EPS$0.92
Beat 114.0%
Q4 201827 Feb
EPS$2.42
Beat 511.7%
Q3 20186 Nov
EPS$-0.03
Beat 81.3%
Q2 20187 Aug
EPS$-0.05
Miss 222.2%
Q1 20184 May
EPS$-0.01
Miss 61.5%
Q4 201727 Feb
EPS$0.02
Beat 125.0%
Q3 20177 Nov
EPS$-0.02
Beat 58.0%
Q2 20178 Aug
EPS$-0.09
Miss 125.0%
Q1 20179 May
EPS$0.03
Beat 130.0%
Q4 201628 Feb
EPS$0.24
Beat 300.0%
Q3 20169 Nov
EPS$0.06
Miss 25.0%
Q2 20169 Aug
EPS$-0.47
Beat 11.3%
Q1 20164 May
EPS$-0.52
Miss 4.0%
Q4 201525 Feb
EPS$-0.59
Miss 22.9%
Q3 20159 Nov
EPS$-0.30
Beat 3.2%
Q2 20154 Aug
EPS$0.29
Beat 0.0%
Q1 20155 May
EPS$-0.14
Beat 30.0%
Q4 201427 Feb
EPS$0.16
Beat 928.3%
Q3 20147 Nov
EPS$-0.23
Miss 15.0%
Q2 20144 Aug
EPS$-0.10
Beat 23.1%
Q1 20146 May
EPS$-0.27
Miss 12.5%
Q4 201328 Feb
EPS$-0.21
Miss 23.5%
Q3 20135 Nov
EPS$-0.21
Beat 22.2%
Q2 20136 Aug
EPS$-0.09
Beat 57.1%
Q1 20137 May
EPS$-0.03
Miss 22.8%
Q4 201228 Feb
EPS$-0.23
Beat 0.0%
Q3 20126 Nov
EPS$-0.33
Miss 26.9%
Q2 20126 Aug
EPS$-0.01
Beat 88.0%
Q1 20128 May
EPS$-0.24
Beat 7.7%
Q4 201129 Feb
EPS$-0.20
Miss 11.1%
Q3 20117 Nov
EPS$-0.27
Miss 28.6%
Q2 20114 Aug
EPS$-0.18
Beat 18.2%
Q1 20115 May
EPS$-0.20
Miss 5.3%
Q4 201028 Feb
EPS$-0.14
Beat 36.4%
Q3 20104 Nov
EPS$-0.13
Beat 35.0%
Q2 20109 Aug
EPS$-0.25
Miss 66.7%
Q1 20106 May
EPS$-0.10
Beat 41.2%
Q4 20091 Mar
EPS$-0.17
Miss 54.5%
Q3 20095 Nov
EPS$-0.07
Beat 0.0%
Q2 20096 Aug
EPS$-0.03
Miss 44.0%
Q1 20097 May
EPS$1.76
Beat 3.5%
Q4 200825 Feb
EPS$-0.09
Miss 125.0%
Q3 200810 Nov
EPS$0.03
Beat 160.0%
Q2 20087 Aug
EPS$-0.02
Beat 60.0%
Q1 200812 May
EPS$-0.05
Beat 50.0%
Q4 200713 Mar
EPS$-0.08
Miss 331.5%
Q3 20078 Nov
EPS$-1.25
Miss 933.3%
Q2 20078 Aug
EPS$-0.13
Beat 23.5%
Q1 200710 May
EPS$-0.16
Beat 33.3%
Q4 20068 Mar
EPS$-0.18
Miss 5.9%
Q3 20062 Nov
EPS$-0.16
Beat 36.0%
Q2 20063 Aug
EPS$-0.03
Beat 89.3%
Q1 20062 May
EPS$-0.24
Beat 0.0%
Q4 20059 Mar
EPS$-0.11
Beat 31.3%
Q3 20058 Nov
EPS$-0.24
Beat 11.1%
Q2 20058 Aug
EPS$-0.34
Miss 9.7%
Q1 20055 May
EPS$-0.52
Miss 73.3%
Q4 20041 Mar
EPS$-1.00
Miss 127.3%
Q3 200427 Oct
EPS$-0.57
Miss 32.6%
Q2 20045 Aug
EPS$-0.47
Miss 2.2%
Q1 20046 May
EPS$-0.47
Miss 14.6%
Q4 200310 Feb
EPS$-0.46
Miss 15.0%
Q3 20034 Nov
EPS$-0.40
Miss 5.3%
Q2 20035 Aug
EPS$-0.42
Miss 7.7%
Q1 20038 May
EPS$-0.44
Miss 37.5%
Q4 200231 Mar
EPS$-0.29
Q3 20026 Nov
EPS$-0.33
Miss 6.5%
Q2 200230 Jul
EPS$-0.39
Miss 11.4%
Q1 200223 Apr
EPS$-0.34
Beat 0.0%
Q1 20021 Apr
EPS$-0.29
Q3 200117 Oct
EPS$-0.29
Miss 26.1%
Q2 200125 Jul
EPS$-0.58
Miss 34.9%
Q1 200115 May
EPS$-0.57
Q4 20007 Feb
EPS$-0.40
Miss 17.6%
Q3 20002 Nov
EPS$-0.15
Beat 55.9%
Q2 200010 Aug
EPS$-0.40
Miss 17.6%
Q1 200010 May
EPS$-0.56
Beat 5.1%
Q4 199928 Mar
EPS$-0.61
Q3 199927 Oct
EPS$-0.44
Beat 4.3%
Q2 199929 Jul
EPS$-0.51
Beat 30.1%
Q1 199929 Apr
EPS$-0.47
Miss 6.8%
Q4 199831 Mar
EPS$-0.67
Q3 19983 Nov
EPS$-0.04
Beat 92.3%
Q2 199829 Jul
EPS$-0.52
Miss 10.6%
Q1 199829 Apr
EPS$-0.43
Beat 8.5%
Q4 199719 Mar
EPS$-0.40
Q3 199722 Oct
EPS$-0.08
Beat 42.9%
Q2 199730 Jul
EPS$-0.36
Miss 20.0%
Q1 19971 May
EPS$-0.33
Miss 22.2%
Q4 199624 Mar
EPS$-0.31
Q3 199623 Oct
EPS$-0.23
Beat 28.1%
Q2 199624 Jul
EPS$-0.29
Miss 7.4%
Q4 199531 Mar
EPS$-0.20
Q3 199531 Dec
EPS$-0.24
Q2 199530 Sept
EPS$-0.32
Q2 199526 Jul
EPS$-0.30
Beat 9.1%
Q1 199526 Apr
EPS$-0.30
Beat 3.2%
Q4 19946 Feb
EPS$-0.31
Beat 6.1%
Q3 199431 Oct
EPS$-0.27
Beat 20.6%
Q2 199427 Jul
EPS$-0.26
Beat 21.2%
Q1 199421 Apr
EPS$-0.23
Beat 47.7%
Q4 19932 Feb
EPS$-0.28
Beat 37.8%
Q3 19932 Nov
EPS$-0.30
Beat 25.0%
Q2 199330 Jul
EPS$-0.31
Beat 22.5%
Q1 199330 Apr
EPS$-0.34
Beat 17.1%
Q4 199224 Feb
EPS$-0.41
Beat 0.0%
Q2 199230 Sept
EPS$-0.38
Q1 199230 Jun
EPS$-0.33
Q4 199131 Mar
EPS$-0.39
Q3 199131 Dec
EPS$-0.31
Q2 199130 Sept
EPS$-0.23
Q1 199130 Jun
EPS$-0.22
Q4 199031 Mar
EPS$-0.13
Q3 199031 Dec
EPS$-0.13
Q2 199030 Sept
EPS$-0.18
Q1 199030 Jun
EPS$-0.18
Q4 198931 Mar
EPS$-0.18

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about IONS

Which members of Congress have traded IONS?
1 member of Congress has disclosed 2 trade in Ionis Pharmaceuticals, Inc. (IONS) under the STOCK Act: Sheldon Whitehouse.
When was IONS most recently disclosed by Congress?
The most recent IONS disclosure was a sale by Sheldon Whitehouse on 20 January 2016.
What is the total disclosed congressional trading volume for IONS?
Members of Congress have disclosed approximately $16K in IONS sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in IONS?
This IONS page updates as soon as new STOCK Act disclosures are filed for Ionis Pharmaceuticals, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.